Speakers 2019

The following speakers will lecture at PharmaLab 2019:

• Dr Alexander Bartes, Roche Diagnostics. Senior Quality Control Manager.
• Ulla Bondegaard, Novo Nordisk. Currently responsible for maintaining cross-organisational (and cross-country) laboratory processes.
• Phil Borman, GSK. Product Development.
• Dr Christopher Burgess, Burgess Analytical Consultancy. Chairman of the ECA Analytical Quality Control Working Group. Qualified Person” in the EU. Member of the USP Expert Panel on Validation and Verification entrusted to revise General Chapters.
• Chiara Celli, Merck. Scientist Microbiological ID.
• Dr Jörg Degen, Eurofins BioPharma Product Testing. Head of Microbiology.
• Dr Sven M. Deutschmann, Roche Diagnostics. Head of Global ASAT "Adventitious Agents Testing and Alternative Microbiologica. Chairman of the Advisory Board of the ECA “Pharmaceutical Microbiology Interest Group”, Member of PDA Task Forces.
• Silviya Dimitrova, TEVA. Member of the ECA QC Group Board and QP. Overall responsibility for quality oversight of European TEVA suppliers as well as QC and QP Release.
• Dr Christie English, Mycoplasma Experience, Scientist - Molecular Biology
• Thomas Fechner, Agilent Technologies. Principal Scientist.
• Dr Anja Fritsch, Confarma. Responsible for cell based bioassays (development and routine).
• Barbara Gerten, Merck. Chairwoman DIN Working Group Microbiological Food Testing incl. Rapid Methods.
• Dr Eelo Gitz, Sanquin Reagents. Project manager product development.
• Dr Marcus Gutmann, Microcoat Biotechnologie. Project Leader Endotoxin Services.
  
• Dr Qing He, Chinese National Institutes for Food and Drug Control. Pharmacology Division.
• Dr Jessica Hankins, U.S. Food and Drug Administration
• Christiane Höfner, Labor LS. Senior Expert Microbiological Testing.
• Patrick Jackson, GSK. Investigator in CMC-Analytical.
• Dr Gerd Jilge, Boehringer Ingelheim. Quality Control. Member of the EDQM expert group 11 and Board Member of the ECA QC Group.
• Dr David Jones, Rapid Micro Biosystems. Technical Services Director.
• Dr Ilona Kalaszczynska, Medical University of Warsaw. Scientist at University Warsaw and QC Manager BMCT.
• Jan-Oliver Karo, Paul-Ehrlich Institut, German Federal Agency for Vaccines and Biomedicines
  Division Microbial Safety. Quality assessor and national expert advisor for the microbial safety of ATMPs. Member of the “Cell Therapy Products” Working Party of the German Pharmacopoeia Commission.
• Dr Prasanna Khot, Charles River Laboratories. Senior Research Scientist Microbial Solutions.
• Annette Kunz, CSL Behring. Manager Monitoring.
• Dr Claude Lemarié, Center for Cell Therapy Marseille. QC Management.
• Thomas Ludwig, VelaLabs – A Tentamus Company. Group Leader for cell-based assays.
• Marine Marius, Sanofi Pasteur. Scientist in Analytical R&D Microbiology.
• Bob McDowall, R.D. McDowall Limited. Director.
• Dr Michael J. Miller, Microbiology Consultants. Global expert in rapid methods, validation and pharmaceutical microbiology.
• Dr Hikaru Mizumura, Seikagaku Corporation.
  
• Dr Félix A. Montero Julian, bioMerieux. Scientific Director.
• Alexander Negwer, PEI, German Federal Agency for Vaccines and Biomedicines. Scientist Section 1/3, “Microbial Safety and Parasitology”.
• Kai Nesemann, Sartorius Labs Instrument. Global Product Manager DNA-based rapid QC-testing.
• Dr Jelena Novakovich, Galenika. Senior Expert Associate.
• Kham Nguyen, Rapid Micro Biosystems. QC Scientist.
• Diarmaid O’Riordan, Pfizer. QC Microbiologist.
• Dr Claudia Papewalis, Valicare. Senior GMP Consultant.
• Diana Patzelt, Sartorius Stedim Biotech. Scientist - Applications for Molecular Biology.
• Katrin Pauls, Lonza. Market Development and Scientific Affairs Manager.
• Joseph Pierquin, Redberry. Chief Technical Officer.
• Dr Johannes Reich, Microcoat Biotechnologie. General Manager.
• Nicola Reid, Charles River Laboratories. Senior Product Manager.
• Stéphanie Richard, Sanofi Pasteur. Scientist-Analitycal Sciences Department-Immunology platform.
• Dr Antonio Rodríguez Acosta, Andalusian Initiative for Advanced Therapies. Quality Manager and Deputy Qualified Person at Cell Manufacturing Unit (Regional University Hospital, Málaga. Spain).
• Dr Ruth Röder, Microcoat Biotechnologie. Project Manager Endotoxin Services.
• Dr Sigrid Roosendaal, Quality RA. Senior Consultant.
• Dr David Roesti, Novartis Pharma Stein. Technical Steward Microbiology, Manufacturing Science & Technology.
• Markus Roucka, VelaLabs – A Tentamus Company. Lab Head and Business Development.
• Margarita Sabater Dako Denmark, an Agilent Technologies Company. Manager Compliance Support at Dako. Board Member of the ECA QC Group.
• Christiana Schnitzler, Boehringer Ingelheim. Head Mycoplasma Laboratory.
• Prof. Dr. Hartwig Schulz, Consulting and Project Management for Medicinal and Aroma Plants. Used to work for the Julius Kühn Institute.
• Dr Gerold Schwarz, Bruker Daltronics. Manager Application Support.
• Dr Milanka Setina, National Control Laboratory Medicines and Medical Devices Agency of Serbia. Scientist.
• Dr Ingo Spreitzer, Paul-Ehrlich-Institut, German Federal Agency for Vaccines and Biomedicines. Deputy Head of Section 1/3, “Microbial Safety and Parasitology”.
• Natascha Staub, Mibelle. Microbiological QC.
• Dr Peter Steinhardt, Roche Diagnostics. International Alliance Manager, Business Development Pharma & Biotech, EMEA LATAM.
• Andrej Steyer, University of Ljubljana. Institute of Microbiology and Immunology Faculty of Medicine.
• Jonas van den Berg, Roche. Validation of the Celsis-based Alternative Sterility Test.
• Kevin Williams, BioMerieux. Endotoxin Expert.
• Veronika Wills, Associates of Cape Cod. Manager Technical Services.